These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2345562)

  • 21. Thyrotoxic periodic paralysis and the sodium/potassium pump.
    Marx A; Ruppersberg JP; Pietrzyk C; Rüdel R
    Muscle Nerve; 1989 Oct; 12(10):810-5. PubMed ID: 2558311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis.
    Tricarico D; Servidei S; Tonali P; Jurkat-Rott K; Camerino DC
    J Clin Invest; 1999 Mar; 103(5):675-82. PubMed ID: 10074484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of insulin receptors to hypokalemic periodic paralysis.
    Hofmann WW; Adornato BT; Reich H
    Muscle Nerve; 1983 Jan; 6(1):48-51. PubMed ID: 6341831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Decrease of the contraction force of skeletal muscle in mammals by the potassium channel activator, SR 44866].
    Findlay I; Sauviat MP
    C R Acad Sci III; 1990; 310(11):489-94. PubMed ID: 2114192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Speculations on hypokalemic periodic paralysis.
    Zierler KL
    Am J Med Sci; 1973 Aug; 266(2):130-3. PubMed ID: 4742367
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanical and electrophysiological effects of cromakalim on the human urinary bladder.
    Wammack R; Jahnel U; Nawrath H; Hohenfellner R
    Investig Urol (Berl); 1994; 5():159-64. PubMed ID: 7719299
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of cromakalim on ischemic and reperfused immature heart: experiments with isolated neonatal New Zealand white rabbit hearts.
    Shimoe Y; Yoshizumi M; Masuda Y; Kitagawa T; Katoh I
    Tokushima J Exp Med; 1996 Dec; 43(3-4):135-41. PubMed ID: 9100462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic profiles of YM934, a novel potassium channel opener.
    Uchida W; Masuda N; Taguchi T; Shibasaki K; Shirai Y; Asano M; Matsumoto Y; Tsuzuki R; Fujikura T; Takenaka T
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):180-7. PubMed ID: 7511745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current status of clinical and molecular-biological research on familial periodic paralysis].
    Shishiba Y
    Nihon Rinsho; 1997 Dec; 55(12):3239-46. PubMed ID: 9436444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hypokalemic periodic paralysis.
    Campa JF; Sanders DB
    Arch Neurol; 1974 Aug; 31(2):110-5. PubMed ID: 4834972
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of cromakalim on intracellular [Ca2+] in isolated rat skeletal muscle during fatigue and metabolic blockade.
    Burton FL; Smith GL
    Exp Physiol; 1997 May; 82(3):469-83. PubMed ID: 9179567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium activation of electrically inexcitable muscle fibers in primary hypokalemic periodic paralysis.
    Engel AG; Lambert EH
    Neurology; 1969 Sep; 19(9):851-8. PubMed ID: 5816878
    [No Abstract]   [Full Text] [Related]  

  • 34. Muscle fiber conduction velocity in the diagnosis of sporadic hypokalemic periodic paralysis.
    Brouwer OF; Zwarts MJ; Links TP; Wintzen AR
    Clin Neurol Neurosurg; 1992; 94(2):149-51. PubMed ID: 1324813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of cromakalim on the detrusor muscle of human and pig urinary bladder.
    Foster CD; Speakman MJ; Fujii K; Brading AF
    Br J Urol; 1989 Mar; 63(3):284-94. PubMed ID: 2702427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypokalemic periodic paralysis studies in vitro.
    Hofmann WW; Smith RA
    Brain; 1970; 93(3):445-74. PubMed ID: 5507013
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.
    Angerbach D; Nicholson CD
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):341-6. PubMed ID: 3393236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atracurium use in a patient with familial periodic paralysis.
    Laurito CE; Becker GL; Miller PE
    J Clin Anesth; 1991; 3(3):225-8. PubMed ID: 1878236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal and pharmacological modification of plasma potassium homeostasis.
    Clausen T
    Fundam Clin Pharmacol; 2010 Oct; 24(5):595-605. PubMed ID: 20618871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses.
    Bandschapp O; Iaizzo PA
    Paediatr Anaesth; 2013 Sep; 23(9):824-33. PubMed ID: 23802937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.